Replies to post #189 on Mereo BioPharma Group PLC (MREO)

[stocksrising]

Between affirming buy rating (Mereo BioPharma Group Price Target Maintained With a $5.00/Share by Needham) and interim data soon( Orbit study), Mkt makers keeping It above $1 ( we need 20consec days to stay on Nasdaq I think) .. also, company said in recent release —- ‘In line with previous guidance by the Company, Mereo is exploring potential partnerships to fund the Phase 3 study’…

We shall see, GLTA